Related Experiment Videos

Plasma fibronectin and serum complement C3 levels in chronic active hepatitis following virus "B" versus virus "C"

M M Abdel Rahman1, M S el Nasr, S A Mahmoud

  • 1Department of Tropical Medicine, Faculty of Medicine, Al-Azhar University, Cairo.

Insights

Chronic active hepatitis (CAH) patients showed elevated fibronectin levels. Those with hepatitis C (CAH-C) had higher fibronectin than hepatitis B (CAH-B) patients, suggesting more inflammation in CAH-C.

Area of Science:

  • Hepatology
  • Immunology
  • Biochemistry

Background:

  • Chronic active hepatitis (CAH) is an inflammatory liver condition.
  • Distinguishing the severity of CAH based on viral etiology is crucial for patient management.
  • Biomarkers can indicate disease activity and inflammatory processes.

Purpose of the Study:

  • To compare plasma fibronectin and serum complement C3 levels in patients with CAH post hepatitis B versus CAH post hepatitis C.
  • To assess the relationship between these biomarkers and the inflammatory status in different CAH groups.

Main Methods:

  • Quantification of plasma fibronectin and serum complement C3 levels using biochemical assays.
  • Comparison of biomarker levels between three groups: CAH post-B (n=30), CAH post-C (n=30), and healthy controls (n=20).

Main Results:

  • Significantly elevated fibronectin levels were observed in CAH patients compared to healthy controls.
  • Fibronectin levels were significantly higher in CAH patients with hepatitis C compared to those with hepatitis B.
  • No significant differences in serum complement C3 levels were found across the studied groups.

Conclusions:

  • Plasma fibronectin may serve as a potential indicator of inflammatory damage in chronic active hepatitis.
  • Hepatitis C infection might be associated with a more pronounced inflammatory response in CAH compared to hepatitis B infection.

Related Concept Videos